Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death. - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Journal of Immunology Année : 2008

Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death.

Résumé

Patterns of change in cell volume and plasma membrane phospholipid distribution during cell death are regarded as diagnostic means of distinguishing apoptosis from necrosis, the former being associated with cell shrinkage and early phosphatidylserine (PS) exposure, whereas necrosis is associated with cell swelling and consequent lysis. We demonstrate that cell volume regulation during lymphocyte death stimulated via the purinergic receptor P2X7 is distinct from both. Within seconds of stimulation, murine lymphocytes undergo rapid shrinkage concomitant with, but also required for, PS exposure. However, within 2 min shrinkage is reversed and swelling ensues ending in cell rupture. P2X7-induced shrinkage and PS translocation depend upon K+ efflux via KCa3.1, but use a pathway of Cl- efflux distinct from that previously implicated in apoptosis. Thus, P2X7 stimulation activates a novel pathway of cell death that does not conform to those conventionally associated with apoptosis and necrosis. The mixed apoptotic/necrotic phenotype of P2X7-stimulated cells is consistent with a potential role for this death pathway in lupus disease.

Domaines

Immunologie
Fichier non déposé

Dates et versions

hal-00294279 , version 1 (09-07-2008)

Identifiants

  • HAL Id : hal-00294279 , version 1
  • PUBMED : 18097031

Citer

Simon R J Taylor, Mireya Gonzalez-Begne, Stephen Dewhurst, Giovanna Chimini, Christopher F Higgins, et al.. Sequential shrinkage and swelling underlie P2X7-stimulated lymphocyte phosphatidylserine exposure and death.. Journal of Immunology, 2008, 180 (1), pp.300-8. ⟨hal-00294279⟩

Collections

CNRS UNIV-AMU
35 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More